Citigroup »

Viking Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.0M 269k 18.61
2023-09-30 $4.0M 360k 11.07
2023-03-31 $9.4M 565k 16.65
2022-12-31 $1.2M 128k 9.40
2022-09-30 $21k 5.4k 3.88
2021-12-31 $867k 189k 4.60
2021-03-31 $2.5M 433k 5.75
2020-12-31 $531k 92k 5.75
2020-09-30 $376k 65k 5.75
2020-06-30 $1.0M 149k 6.90
2020-03-31 $702k 150k 4.68
2019-12-31 $1.5M 191k 8.02
2019-09-30 $2.6M 376k 6.87
2019-06-30 $5.3M 636k 8.30
2019-03-31 $1.2M 119k 9.94
2018-12-31 $7.5M 976k 7.66
2018-09-30 $6.5M 371k 17.42
2018-06-30 $85k 9.0k 9.43